Carmustine, vincristine, and prednisone in the treatment of canine lymphosarcoma

Journal of the American Animal Hospital Association

Volumn 40, Issue 4, 2004, Pages 292-299

  Lucas, Silvia Regina Ricci ^a   Coelho, Bruna Maria Pereira ^a   Marquezi, Maurício Luis ^a   Franchini, Maria Luisa ^a   Miyashiro, Samantha Ive ^a   de Benedetto Pozzi, Diana Helena ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CARMUSTINE; PREDNISONE; VINCRISTINE;

ALOPECIA; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER GRADING; CANCER REGRESSION; CANCER SURVIVAL; DIARRHEA; DOG DISEASE; DRUG EFFICACY; DRUG FEVER; FEMALE; HYPERPIGMENTATION; LIVER DYSFUNCTION; LYMPHOSARCOMA; MALE; NEUTROPENIA; NONHUMAN; THROMBOCYTOPENIA; VOMITING;

CANIS FAMILIARIS;

EID: 31844455563     PISSN: 15473317     EISSN: 15473317     Source Type: Journal    
DOI: 10.5326/0400292     Document Type: Article

References (27)

1. Couto CG. Canine lymphomas: something old, something new. Compend Contin Educ Pract Vet 1985;7:291-302.
2. Brick JO, Roegnigk WJ, Wilson GP. Chemotherapy of malignant lymphoma in dogs and cats. J Am Vet Med Assoc 1968;153:47-52.
3. Cotter SM. Treatment of lymphoma and leukemia with cyclophosphamide, vincristine and prednisone I. Treatment of dogs. J Am Anim Hosp Assoc 1983;19:159-165.
4. Ogilvie GK, Vail DM, Klein MK, et al. Weekly administration of low-dose doxorubicin for treatment of malignant lymphoma in dogs. J Am Vet Med Assoc 1981;198:1762-1764.
5. Rosenthal RC, MacEwen EG. Treatment of lymphoma in dogs. J Am Vet Med Assoc 1990;196:774-781.
6. Stone MS, Golstein MA, Cotter SM. Comparison of two protocols for induction of remission in dogs with lymphoma. J Am Anim Hosp Assoc 1991;27:315-321.
7. Greenlee PG, Filippa. DA, Quimby FW. Lymphoma in dogs: a morphologic, immunologic and clinical study. Cancer 1990;66:480-489.
8. Moore AS, London CA, Wood CA, et al. Lomustine (CCNU) for the treatment of resistant lymphoma in dogs. J Vet Intern Med 1999;13:395-398.
9. Teske E. Canine malignant lymphoma: a review and comparison with human non-Hodgkin's lymphoma. Vet Quart 1994;16:209-219.
10. Rosenthal RC. Lymphoma in dogs. Vet Clin North Am Small Anim Pract 1996;26:63-85.
11. De Vita VT. Principles of chemotherapy. In: De Vita VT, Hellman S, Rosenberg AS, eds. Cancer: Principles and Practice of Oncology. Philadelphia: Lippincott, 1989:276-300.
12. Dimsky DS, Cook JR. Carmustine-induced partial remission of an astrocytoma in a dog. J Am Anim Hosp Assoc 1990;26:179-182.
13. Weiss RB, Issel BF. The nitrosoureas: carmustine (BCNU) and lomustine (CCNU). Cancer Treat Rev 1982;9:313-330.
14. Tew KD, Colvin M, Chabner BA. Alkylant agents. In: Chabner BA, Longo DL, eds. Cancer Chemotherapy and Biotherapy. 2nd ed. Philadelphia: Lippincott, 1996:302-332.
15. Coppoc GL. Chemotherapy of neoplastic diseases. In: Booth NH, Me Donald LE, eds. Veterinary Pharmacology and Therapeutics. 6th ed. Iowa: Iowa State Univ Press, 1988:861-876.
16. Reynolds JEF. Martindale: The Extra Pharmacopoeia. 31st ed. The Royal Pharmaceutical Society, 1996:550.
17. Owen L. WHO clinical staging. In: Document VPH/CMO/80,20. Geneva: World Health Organization, 1980:47.
18. Boyce KL, Kitchell BE. Treatment of canine lymphoma with COPLA/LVP. J Am Anim Hosp Assoc 2000;36:395-403.
19. Chun R, Garrett LD, Vail DM. Evaluation of high-dose chemotherapy protocol with no maintenance therapy for dogs with lymphoma. J Vet Intern Med 2000;14:120-124.
20. Teske E, Rutteman GR, Heerde P Van, et al. Polyethylene glycol-L-asparaginase in canine non-Hodgkin's lymphoma. Eur J Cancer 1990;26:891-895.
21. MacEwen EG, Brown NO, Patnaik AK, et al. Cyclic combination chemotherapy of canine lymphosarcoma. J Am Vet Med Assoc 1981;178:1178-1181.
22. MacEwen EG, Hayes AA, Matus RE. Some prognostic factors for advanced multicentric canine lymphosarcoma. J Am Vet Med Assoc 1987;190:564-568.
23. Teske E, Heerde P Van, Rutteman GR, et al. Prognostic factors for treatment of malignant lymphoma in dogs. J Am Vet Med Assoc 1994;205:1722-1728.
24. Miyashiro SI, Hagiwara MK, Brandõ LP, et al. Bone marrow toxicity induced by carmustine (BCNU) in dogs. In: World Small Animal Veterinary Association World Congress, 26. 2001, Vancouver. CD-ROM.
25. Rosenthal RC. Clinical applications of vinka alkaloids. J Am Vet Med Assoc 1982;179:1084-1086.
26. Myers III NC, Moore AS, Rand WM, et al. Evaluation of a multi-drug chemotherapy procotol (ACOPA II) in dogs with lymphoma. J Vet Intern Med 1997;11:333-339.
27. Price GS, Frazier DL. Use of body surface area (BSA)-based dosages to calculate chemotherapeutic drug dose in dogs: I Potential problems with current BSA formulae. J Vet Intern Med 1998;12:267-271.